Deep-pocketed investors have adopted a bullish approach towards TransMedics Gr TMDX, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in TMDX usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 11 extraordinary options activities for TransMedics Gr. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 54% leaning bullish and 36% bearish. Among these notable options, 6 are puts, totaling $323,339, and 5 are calls, amounting to $477,747.
What's The Price Target?
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $40.0 to $150.0 for TransMedics Gr over the recent three months.
Volume & Open Interest Trends
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for TransMedics Gr's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of TransMedics Gr's whale activity within a strike price range from $40.0 to $150.0 in the last 30 days.
TransMedics Gr 30-Day Option Volume & Interest Snapshot
Noteworthy Options Activity:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TMDX | CALL | TRADE | BULLISH | 07/18/25 | $15.4 | $15.0 | $15.3 | $55.00 | $153.0K | 87 | 211 |
| TMDX | CALL | TRADE | BEARISH | 07/18/25 | $15.4 | $15.1 | $15.2 | $55.00 | $152.0K | 87 | 101 |
| TMDX | PUT | SWEEP | BEARISH | 04/17/25 | $6.1 | $6.0 | $6.0 | $50.00 | $118.2K | 582 | 170 |
| TMDX | CALL | SWEEP | BULLISH | 07/18/25 | $15.5 | $15.2 | $15.3 | $55.00 | $97.9K | 87 | 275 |
| TMDX | PUT | TRADE | BULLISH | 04/17/25 | $6.5 | $6.2 | $6.32 | $50.00 | $56.8K | 582 | 318 |
About TransMedics Gr
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
In light of the recent options history for TransMedics Gr, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Present Market Standing of TransMedics Gr
- With a volume of 1,276,047, the price of TMDX is up 0.74% at $58.45.
- RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.
- Next earnings are expected to be released in 38 days.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for TransMedics Gr, Benzinga Pro gives you real-time options trades alerts.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
